CHEMOTHERAPY EFFECT
Clinical trials for CHEMOTHERAPY EFFECT explained in plain language.
Never miss a new study
Get alerted when new CHEMOTHERAPY EFFECT trials appear
Sign up with your email to follow new studies for CHEMOTHERAPY EFFECT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Stomach cancer trial combines chemo and Bacteria-Fighting therapy
Disease control Recruiting nowThis study tests whether adding H. pylori bacteria treatment to standard chemotherapy before and after surgery can improve outcomes for people with stomach or gastroesophageal junction cancer. About 198 adults with H. pylori-positive, locally advanced cancer will be randomly assi…
Matched conditions: CHEMOTHERAPY EFFECT
Phase: PHASE2 • Sponsor: Sixth Affiliated Hospital, Sun Yat-sen University • Aim: Disease control
Last updated May 26, 2026 03:16 UTC
-
New hope for esophageal cancer: study tests best Pre-Surgery combo
Disease control Recruiting nowThis study aims to find the best treatment before surgery for people with esophageal or stomach cancer. It compares chemotherapy, chemoradiation, targeted therapy, and immunotherapy. The goal is to improve survival and reduce side effects. About 2000 adults with stage I to IVa ca…
Matched conditions: CHEMOTHERAPY EFFECT
Phase: PHASE3 • Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences • Aim: Disease control
Last updated May 26, 2026 03:11 UTC
-
Could a liver pill boost chemo for leukemia?
Disease control Recruiting nowThis study tests whether adding silibinin (a liver-protecting supplement) to standard chemotherapy can improve outcomes for people newly diagnosed with acute myeloid leukemia (AML). About 100 adults will be randomly assigned to receive chemo with or without silibinin. The goal is…
Matched conditions: CHEMOTHERAPY EFFECT
Phase: PHASE4 • Sponsor: Fujian Medical University Union Hospital • Aim: Disease control
Last updated May 22, 2026 13:51 UTC
-
New hope for esophageal cancer: testing immunotherapy with standard chemoradiation
Disease control Recruiting nowThis study aims to find the best treatment plan for people with esophageal or esophagogastric junction cancer that cannot be removed by surgery. It will test adding immunotherapy (PD-1/PD-L1 antibodies) or targeted drugs to the standard chemoradiotherapy. About 2000 adults with s…
Matched conditions: CHEMOTHERAPY EFFECT
Phase: PHASE3 • Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences • Aim: Disease control
Last updated May 19, 2026 12:00 UTC
-
New hope for inoperable liver cancer: targeted artery treatments show promise
Disease control Recruiting nowThis study is for people with a type of liver cancer (intrahepatic cholangiocarcinoma) that cannot be removed by surgery. It compares two treatments delivered directly to the liver's blood supply—HAI-FUDR/DEX and SIRT—both given alongside standard chemotherapy. The goal is to shr…
Matched conditions: CHEMOTHERAPY EFFECT
Phase: PHASE2 • Sponsor: Oslo University Hospital • Aim: Disease control
Last updated May 18, 2026 12:10 UTC
-
New drug cocktail shows promise in slowing advanced liver cancer
Disease control Recruiting nowThis study tests whether adding chemotherapy to a combination of two drugs (camrelizumab and apatinib) helps people with advanced liver cancer live longer without their disease getting worse. About 326 adults with liver cancer that cannot be removed by surgery will be randomly as…
Matched conditions: CHEMOTHERAPY EFFECT
Phase: PHASE3 • Sponsor: Linhui Peng • Aim: Disease control
Last updated May 18, 2026 12:09 UTC
-
New combo therapy aims to slow advanced liver cancer
Disease control Recruiting nowThis phase 3 trial tests two different ways to give chemotherapy combined with immunotherapy and a targeted drug for people with advanced liver cancer (BCLC stage C). One group gets standard IV chemo, the other gets chemo directly into the liver artery. The goal is to see which a…
Matched conditions: CHEMOTHERAPY EFFECT
Phase: PHASE3 • Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University • Aim: Disease control
Last updated May 12, 2026 13:42 UTC
-
Massage may help young cancer patients catch Zzz's
Symptom relief Recruiting nowThis study looks at whether massage therapy can improve sleep for children aged 12 to 21 who are in the hospital for cancer treatment or a stem cell transplant. About 70 participants will either receive standard care or add massage therapy to their routine. Researchers will track…
Matched conditions: CHEMOTHERAPY EFFECT
Phase: NA • Sponsor: Children's Hospital of Philadelphia • Aim: Symptom relief
Last updated May 26, 2026 03:11 UTC
-
Phone app aims to clear fog of chemobrain for cancer patients
Symptom relief Recruiting nowThis study tests whether a mobile cognitive training app can reduce 'chemobrain'—memory and thinking problems caused by chemotherapy—in women with gynecologic cancer. About 64 participants will use the app and have their brain function measured with tests and surveys. The goal is…
Matched conditions: CHEMOTHERAPY EFFECT
Phase: NA • Sponsor: University of Alabama at Birmingham • Aim: Symptom relief
Last updated May 26, 2026 03:05 UTC
-
Exercise may protect brain health during chemo, new study says
Symptom relief Recruiting nowThis study looks at whether a 16-week high-intensity interval training (HIIT) program can improve brain function and heart health in women with breast cancer who are receiving chemotherapy. About 30 women will participate, and their thinking skills and fitness will be measured be…
Matched conditions: CHEMOTHERAPY EFFECT
Phase: NA • Sponsor: Dana-Farber Cancer Institute • Aim: Symptom relief
Last updated May 26, 2026 03:03 UTC
-
Beauty treatments may soothe chemo anxiety, new study says
Symptom relief Recruiting nowThis study looks at whether socio-aesthetics (specialized beauty and skincare sessions) can help lower anxiety in people starting chemotherapy for cancer. About 192 patients who have never had chemo before will receive these sessions alongside their treatment. Researchers will me…
Matched conditions: CHEMOTHERAPY EFFECT
Phase: NA • Sponsor: GCS Ramsay Santé pour l'Enseignement et la Recherche • Aim: Symptom relief
Last updated May 01, 2026 16:00 UTC